<DOC>
	<DOCNO>NCT02180997</DOCNO>
	<brief_summary>The purpose study investigate pharmacokinetic drug interaction Solifenacin Tamsulosin healthy male volunteer .</brief_summary>
	<brief_title>Clinical Trial Investigate Pharmacokinetic Drug Interaction Between Solifenacin Tamsulosin</brief_title>
	<detailed_description>Pharmacokinetic Drug Interaction Between Solifenacin 10mg Tamsulosin 0.4mg Healthy Male Volunteers</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>19~45 year healthy male Body weight 55kg , BMI measurement 18.0kg/m^2~ 27.0kg/m^2 Signed inform consent form participate voluntarily comply trial requirement . Researchers determine suitable volunteer physical examination , laboratory test History clinically significant liver , kidney , nervous system , immune system , respiratory , endocrine disorder tumor blood disorder , cardiovascular disease , mental disorder ( mood disorder , obsessivecompulsive disorder , etc . ) Sitting SBP &gt; 150mmHg &lt; 100mmHg , sit DBP &gt; 100mmHg &lt; 60mmHg , 3 minute break An impossible one participant clinical trial investigator 's decision include laboratory test result another reason . Have gastrointestinal disease history affect drug absorption ( Crohn 's disease ulcer , etc ) surgery ( except simple appendectomy hernia surgery ) History drug abuse Positive urine drug screening Administrated investigational product previous clinical trial within 90 day first administration day study . Donated blood within 60 day prior first administration day study .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Î±1-blockers</keyword>
	<keyword>antimuscarinic agent</keyword>
</DOC>